EN PL
ORIGINAL PAPER
Evaluation of reliability of the test used for estimation of particular anti-nuclear antibodies’ specificities
 
More details
Hide details
 
Online publication date: 2010-04-08
 
 
Reumatologia 2009;47(6):311-318
 
KEYWORDS
ABSTRACT
The basic problem in serodiagnostics of autoantibodies concerns situations when at very high ANA titres we cannot estimate the specificity of an autoantibody or, what is even worse, the ANA pattern is partially or totally incompatible with specificities estimated by other immunoenzymatic methods. Solving this problem is the main goal of the presented work. Comparison of four methods of anti-dsDNA assessment gives us only 45% quantitative agreement. Sensitivity of tests used for anti-dsDNA and also ANA-IIF-Hep-2 test, to neutralization by dsDNA, ssDNA and RNA, showed significant lowering of anti-dsDNA antibody levels, up to negativity. Titration of doses of antigens needed for neutralization of used tests showed no differences in neutralizing doses between ds and ssDNA and only neutralizing doses for RNA were 10 times greater.
This unexpected result caused the need to assess specificity and avidity of antibodies eluted by the affinity method. Independently of the antigen used for elution, antibodies showed reactivity with two other antigens, for example: antibodies eluted from ssDNA bound to nitrocellulose also showed reactivity with dsDNA and cardiolipin, and generally they were antibodies of low avidity index.
To summarize, conformation and stability of dsDNA preparations (resulting from presence of denatured DNA fragment in dsDNA molecule) exclude the simple possibility of differentiation of separated antibody pools against DNA and makes (in cases of anti-dsDNA antibody assessment) affinity or avidity estimation necessary. Solving these problems will be possible (as we planned) by using synthetic DNA analogues such as polynucleosides.
 
REFERENCES (24)
1.
von Műhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323-358. .
 
2.
Tan EM. Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine. Adv Immunol 1982; 33: 167-240. .
 
3.
Ząbek J, Palacz A, Musiej-Nowakowska E i wsp. Porównanie wartości diagnostycznej przeciwciał dla nukleosomów z innymi markerami serologicznymi występującymi w toczniu rumieniowatym układowym. Reumatologia 2004; 42: 507-514. .
 
4.
Kadłubowski M, Jackson M, Yap PL, et al. Lack of specificity for antibodies to double stranded DNA found in four commercial kits. J Clin Pathol 1991; 44: 246-250. .
 
5.
Hamann D, Smeenk RJT. dsDNA autoantibodies. Autoantibodies. Elsevier, B.V. 2007; 159-167. .
 
6.
Stollar BD. Immunochemistry of DNA. Int Rev Immunol 1989; 5: 1-22. .
 
7.
Haugbro JC, Nossent T, Winkler Y, et al. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann Rheum Dis 2004; 63: 386-394. .
 
8.
DNA – budowa i właściwości. W: Genetyka molekularna. Węgleński P (red.). PWN, Warszawa 1995; 37-44. .
 
9.
van Venrooij WJ. Autoantigens in connective tissue diseases. Immunology of the connective tissue diseases, ed. GS Panayi. Kluwer Academic Publisher. Dordrecht, Boston, London 1994; 22: 305-334. .
 
10.
Ząbek J. Standaryzacja metod oznaczania autoprzeciwciał markerowych w ramach ECSA – cele a realne efekty. Reumatologia 2005; 43: 179-182. .
 
11.
Maśliński W, Ząbek J, Brzosko M, et al. Standarization of marker autoantibodies in systemic connective tissue diseases. Cent Eur J Immunol 2008; 33: 33. .
 
12.
Maśliński W, Ząbek J, Brzosko M. Standaryzacja w reumatologii. II Sympozjum Standaryzacja w Immunologii. VI Konferencja Naukowo-Szkoleniowa Postępy Immunopatologii w Diagnostyce Klinicznej. Poznań, 27-29 listopada 2008 (materiały Konferencji). .
 
13.
Thomas HI, Morgan-Capner P, Anders G, et al. Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods 1992; 39: 149-155. .
 
14.
Gershoni JM, Poladi GE. Protein blotting: principles and applications. Anal Biochem 1983; 131: 1-34. .
 
15.
Rekvig OP. The immunological basis for selecting anti-dsDNA antibody assays. Glias J 2002; 1: 3-6. .
 
16.
Ząbek J. Przeciwciała antyfosfolipidowe. W: Reumatologia kliniczna. Zimmermann-Górska I (red.). Wydawnictwo Lekarskie PZWL, Warszawa 2008; 201-206. .
 
17.
Kandiah DA, Krilis SA. Immunology and methods of detection of antiphospholipid antibodies. In: The Antiphospholipid Syndrome. Asherson RA, Cervera R, Piette J-Ch, Shoenfeld Y (eds). CRC Press, Boca Raton, New York, London, Tokyo 1996; 29-47. .
 
18.
Ząbek J, Pyka J, Krzewska I, et al. Autoantibodies in systemie lupus erythematosus (SLE). Ann Univ Mariae Curie-Skłodowska Lublin – Polonia 2008; 63: 18-24. .
 
19.
Forger F, Matthias T, Oppermann M, et al. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 2004; 13: 36-44. .
 
20.
Somerfield SD, Roberts MW, Booth RJ. Double-stranded DNA antibodies: a comparison of four methods of detection. J Clin Pathol 1981; 34: 1032-1035. .
 
21.
Raz E, Brezis M, Rosenmann E, Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 1989; 142: 3076-3082. .
 
22.
Poreplikacyjna naprawa przez wycinanie niewłaściwie sparowanych zasad. W: Genetyka molekularna. Węgleński P (red.). PWN, Warszawa 1995; 252-254. .
 
23.
Bruggen MC, Walgreen B, Rilke T, et al. Antigen specificity of antinuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo. Eur J Immunol 1997; 27: 1564-1569. .
 
24.
Bożič B, Čučnik S, Kveder T, et al. Affinity and avidity of autoantibodies. Autoantibodies. Elsevier BV. 2007; 21-28.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top